Market Research Logo

Global Enteric Disease Testing Market 2016-2020

About Enteric Diseases

Enteric diseases are infections caused by ingested bacteria and viruses. Direct contact with contaminated feces or vomit is the secondary mode of contracting enteric ailments. Symptoms of enteric diseases include stomach pain, vomiting, diarrhea, nausea, weight loss, anorexia, and fever. Enteric diseases may lead to stunted growth, malnutrition, and impaired cognitive development. Enteric disease testing is performed on individuals using rapid tests, culture tests, enzyme immunoassay tests, and immunoassay tests.

Technavio’s analysts forecast the global enteric disease testing market to grow at a CAGR of 8.9% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global enteric disease testing market for 2016-2020. To calculate the market size, Technavio uses revenue generated from the sales of enteric disease testing products for Bacterial enterics (Clostridium difficile, Campylobacter, enterohemorrhagic Escherichia coli [EHEC], and Helicobacter pylori) and Viral enterics (Norovirus and Rotavirus) The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Enteric Disease Testing Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Alere
  • bioMérieux
  • Cepheid
  • DiaSorin
Other prominent vendors
  • BD
  • Biomerica
  • Coris BioConcept
  • Meridian Bioscience
  • Mobidiag
  • Quidel
  • Quest Diagnostics
  • R-Biopharm
  • Trinity Biotech
  • Thermo Fisher Scientific
Market driver
  • Increase in adoption of molecular diagnostic testing
  • For a full, detailed list, view our report
Market challenge
  • Lack of awareness in underdeveloped countries
  • For a full, detailed list, view our report
Market trend
  • Shift from singleplex to multiplex testing
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Enteric Disease Testing Market 2016-2020

Technavio recognizes the following companies as the key players in the global enteric disease testing market: Alere, bioMérieux, Cepheid, and DiaSorin.

Other Prominent Vendors in the market are BD, Biomerica, Coris BioConcept, Meridian Bioscience, Mobidiag, Quest Diagnostics, R-Biopharm, Trinity Biotech, and Thermo Fisher Scientific.

Commenting on the report, an analyst from Technavio’s team said that the development of novel NAAT for enteric disease testing is an important trend that will lead to the growth of this market. Currently, PCR represents the gold standard for nucleic acid-based diagnostics. However, the need for variations in temperature increases power consumption and costs for laboratories. Currently, life sciences companies and academics have developed an isothermal amplification-based diagnostic method to circumvent the need for thermocyclers. Isothermal-based methods incorporate all the temperature-dependent steps of PCR by incorporating enzymes. For example, HDA, an isothermal technique of nucleic acid amplification utilizes helicase for complementing the denaturation step at a high temperature, and the entire amplification is completed under isothermal conditions in the range of 140°F-149°F. The method has been used for rapid diagnostics of the E. coli pathogen. This method reduces the cost of instrumentation due to the usage of helicase to separate DNA, which eliminates the need for a thermocycler.

According to the report, high incidence of enteric diseases is one of the key drivers to augment the growth prospects for this market. Enteric diseases are the most common cause of mortality worldwide, after cardiovascular and respiratory diseases. There has been a rise in the incidence of enteric diseases globally over the past decade. For example, each year two billion cases of diarrhea are reported worldwide, and 760,000 children aged five of below succumb to the disease in Sub-Saharan Africa region. The high incidence of enteric diseases increases the demand for screening and testing of infected victims. This, in turn, drives the adoption of diagnostic tests, thereby contributing to market growth.

Further, the report states that stringent regulatory environment are hampering the growth of the market. The regulatory requirements for in vitro diagnostic (IVD) devices worldwide are specific and call for the provision of in-depth technical information, as most of them are classified as class III medical devices. The waiting period for regulatory approvals in the US is long, which can add to developmental expenses and delay return on investment for companies that are involved in the development of the test. In Europe, the 98/79/EC of October 27 Directive is enforced on all in vitro medical diagnostic devices. Canada issues a license to medical products based on the risk category it falls under. This license is issued by the Health Canada authorities and the time taken to issue this license depends on the category of the product. These licenses are subject to annual renewal. Multinational players have to comply with various stringent regulatory conditions of each country in which they operate, which affects their turnaround time, capital expenditure, and profitability.

Companies Mentioned

Alere, bioMérieux, Cepheid, DiaSorin, BD, Biomerica, Coris BioConcept, Meridian Bioscience, Mobidiag, Quest Diagnostics, R-Biopharm, Trinity Biotech, Thermo Fisher Scientific.

  • Executive summary
    • Highlights
  • Scope of the report
    • Market overview
    • Top-vendor offerings
      • Table Product offerings
  • Market research methodology
    • Research methodology
    • Economic indicators
  • Introduction
    • Key market highlights
  • Reimbursement scenario: An overview
    • Table Reimbursement perspectives of healthcare entities
  • Market landscape
    • Market overview
      • Table Global enteric disease testing market
    • Market size and forecast
      • Table Global enteric disease testing market 2015-2020 ($ millions)
    • Five forces analysis
      • Table Five forces analysis
  • Market segmentation by product
    • Table Segmentation of global enteric disease testing market by product 2015
    • Table Distribution of global enteric disease testing market by product 2015 (%)
    • Table Distribution of global enteric disease testing market by product 2020 (%)
    • Table Distribution of global enteric disease testing market by product 2015-2020 (%)
    • Reagents and consumables
      • Table Global enteric disease testing reagent and consumable market 2015-2020 ($ millions)
    • Equipment
      • Table Global enteric disease testing equipment market 2015-2020 ($ millions)
      • Table Global enteric disease testing equipment market by equipment type
    • Large capital equipment
    • Bench-top equipment
    • POC devices
      • Table Distribution of global enteric disease equipment by equipment type 2015 (%)
  • Market segmentation by technique
    • Immunodiagnostics
    • Molecular diagnostics
      • Table Segmentation of global enteric disease testing market by technique 2015
  • Market segmentation by disease type
    • Bacterial enterics
    • Viral enterics
      • Table Segmentation of global enteric disease testing market by microorganism 2015
  • Geographical segmentation
    • Geographical segmentation of global enteric disease testing market 2015-2020
      • Table Segmentation of global enteric disease testing market by geography 2015
      • Table Segmentation of global enteric disease testing market by geography 2020
      • Table Segmentation of global enteric disease testing market by geography 2015-2020
    • Enteric disease testing market in Americas
      • Table Enteric disease testing market in Americas 2015-2020 ($ millions)
    • Enteric disease testing market in EMEA
      • Table Enteric disease testing market in EMEA 2015-2020 ($ millions)
    • Enteric disease testing market in APAC
      • Table Enteric disease testing market in APAC 2015-2020 ($ millions)
  • Market drivers
    • High incidence of enteric diseases
    • Increase in automation and system integration
    • Increase in adoption of molecular diagnostic testing
    • Availability of novel enteric testing platforms
  • Impact of drivers
    • Table Impact of drivers
  • Market challenges
    • Stringent regulatory environment
    • Lack of awareness in underdeveloped countries
    • Shortage of skilled technicians
  • Impact of drivers and challenges
    • Table Impact of drivers and challenges
  • Market trends
    • Development of novel NAAT for enteric disease testing
    • Use of point-of-care tests
    • Shift from singleplex to multiplex testing
    • Increase in public awareness
  • Vendor landscape
    • Competitive scenario
    • Key vendor analysis
      • Table Alere: Key takeaways
      • Table Becton, Dickinson and Company: Key takeaways
      • Table bioMérieux: Key takeaways
      • Table Cepheid: Key takeaways
      • Table DiaSorin: Key takeaways
      • Table Meridian Bioscience: Diagnostics segmentation by revenue 2015
      • Table Meridian Bioscience: Diagnostics geographical segmentation by revenue 2015
      • Table Meridian Bioscience: Key takeaways
      • Table Thermo Fisher Scientific: Key takeaways
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report